Mechanism of benzene-induced hematotoxicity and leukemogenicity: current review with implication of microarray analyses.
Benzene is a potent human leukemogen but the mechanism underlying benzene-induced leukemia remains an enigma due to a number of questions regarding the requirement of extraordinarily long exposure, a relatively low incidence of leukemia for genotoxicity of metabolites and a narrow dose range for leukemogenicity over marrow aplasia (overdoses tend to result in marrow aplasia). Moreover, there were previous controversies as to whether the cell cycle is upregulated or suppressed by the benzene exposure. Subsequently, it was found that the cell cycle is suppressed, but how leukemia develops under such suppression of hemopoiesis remains to be clarified. These questions were fortunately resolved with much effort. Benzene exposure was found to induce the expression of p21, an interlocking counterdevice for cell cycle: due to p53 upregulation, thereby inducing the immediate suppression of the kinetics of hemopoietic progenitors followed by the prominent suppression of hemopoiesis. Intermittent benzene exposure (i.e., cessation of exposure during weekends, for example) allowed an immediate recovery from marrow suppression after terminating exposure, which induced continuous oscillatory changes in marrow hemopoiesis. Benzene-induced leukemia was chiefly due to such an oscillatory change in hemopoiesis, which epigenetically developed leukemia more than 1 year later. The mechanisms of benzene-induced leukemogenicity seem to differ between wild-type mice and mice lacking p53. For p53 knockout mice, DNA damage such as weak mutagenicity or chromosomal damage was retained, and such damage induced consequent activation of proto-oncogenes and related genes, which led cells to undergo further neoplastic changes. In contrast, for wild-type mice carrying the p53 gene, a marked oscillatory change in the cell cycle of the stem cell compartment seems to be important. Compatible and discriminative gene expression profiling between the p53 knockout mice and wild-type mice was observed after benzene exposure by microarray analyses.
Hirabayashi
Yoko
Y
Division of Cellular and Molecular Toxicology, National Institute of Health Sciences, Tokyo 158-8501, Japan.
Yoon
Byung-Il
BI
Li
Guang-Xun
GX
Kanno
Jun
J
Inoue
Tohru
T
D000280:Administration, Inhalation; D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D001554:Benzene / Q000008:administration & dosage* / Q000378:metabolism; D001853:Bone Marrow / Q000187:drug effects; D004249:DNA Damage / Q000187:drug effects / Q000235:genetics; D004260:DNA Repair / Q000187:drug effects / Q000235:genetics; D044127:Epigenesis, Genetic; D020869:Gene Expression Profiling; D016158:Genes, p53; D006402:Hematologic Diseases / Q000139:chemically induced* / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000139:chemically induced* / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D008954:Models, Biological; D020411:Oligonucleotide Array Sequence Analysis; D018336:Receptors, Aryl Hydrocarbon / Q000378:metabolism
D018336:Receptors, Aryl Hydrocarbon; D001554:Benzene